hims glp 1 california & Hers Weight Loss Review (2026) – Forbes Health GLP 1 update ft bad

GLP-1RA activate the cAMP/PKA pathway leading to phosphorylation of sodium-hydrogen exchanger 3 (NHE3) in renal proximal tubular cells, increasing natriuresis and diuresis and lowering blood pressure

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management

but if used improperly (for example, if accidentally infused alone), it can cause serious complications like hemolysis

Neither is inherently superior they operate under different regulatory frameworks, cost structures, and availability